Adzenys Xr-odt Tablet, Orally Disintegrating
Product Images NDC 70165-015

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Adzenys Xr-odt (NDC 70165-015). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Neos Therapeutics Brands, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Adzenys Xr Odt 1

Chemical structure of amphetamine showing a benzene ring attached to a two-carbon chain with an amino group and a methyl group on the second carbon.*

FDA Label Image

Adzenys Xr Odt 2

A pharmacokinetic line graph showing mean plasma concentration (ng/mL) over time (hours) for Dextroamphetamine and Levoamphetamine from two formulations: Amphetamine XR-ODT and MAS ER. The graph compares concentration levels up to 60 hours post-dose, with distinct symbols and lines differentiating each drug and formulation.*

FDA Label Image

Adzenys Xr Odt 3

Packaging label for Adzenys XR-ODT 3.1 mg orally disintegrating tablets by Neos Therapeutics Brands, LLC. The label indicates the product is amphetamine extended-release, with 30 tablets (5 blister cards of 6 tablets each) in a travel case. Instructions include not to crush or chew tablets and to dispense the enclosed Medication Guide with the product.*

FDA Label Image

Adzenys Xr Odt 4

Packaging label for Adzenys XR-ODT 6.3 mg, amphetamine extended-release orally disintegrating tablets. The label shows the product name, strength, dosage form, and instructions such as 'Do not crush or chew tablets.' It includes manufacturer information for Neos Therapeutics Brands, LLC, and states the package contains 30 tablets (5 x 6-count blister cards) in a travel case.*

FDA Label Image

Adzenys Xr Odt 5

Packaging label for Adzenys XR-ODT 9.4 mg extended-release orally disintegrating tablets containing amphetamine, manufactured by Neos Therapeutics Brands, LLC. The label shows the product name, strength, dosage form, NDC 70165-015-30, and usage instructions including a warning not to crush or chew tablets. The package contains 30 tablets in five 6-count blister cards with a travel case.*

FDA Label Image

Adzenys Xr Odt 6

Label for Adzenys XR-ODT 12.5 mg tablets, amphetamine extended-release orally disintegrating tablets. The packaging includes the product name, strength, dosage form, and labeler Neos Therapeutics Brands, LLC. The label also shows the NDC 70165-020-30 and directions for pharmacists to dispense the medication guide. The packaging specifies 30 tablets in blister cards inside a travel case.*

FDA Label Image

Adzenys Xr Odt 7

Packaging label for Adzenys XR-ODT 15.7 mg, an amphetamine extended-release orally disintegrating tablet by Neos Therapeutics Brands, LLC. The label includes dosage strength, product and manufacturer information, NDC 70165-025-30, and instructions for pharmacists to dispense the enclosed Medication Guide. The package contains 30 tablets (5 blister cards of 6 tablets each).*

FDA Label Image

Adzenys Xr Odt 8

Adzenys XR-ODT 18.8 mg extended-release orally disintegrating tablets packaging label. The box displays the product name, strength, and formulation prominently, including cautions such as 'Do not crush or chew tablets.' It contains 30 tablets in blister cards within a travel case. The labeler is Neos Therapeutics Brands, LLC. NDC 70165-030-30 is shown on the packaging.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.